HemaSphere (Jun 2022)

P1530: PERITRANFUSIONAL C1-INHIBITOR IN PATIENTS WITH SEVERE COMPLEMENT-MEDIATED AUTOIMMUNE HEMOLYTIC ANEMIA: AN OPEN LABEL PHASE 2 TRIAL.

  • E. C. W. de Boer,
  • M. Jalink,
  • L. Delvasto-Nuñes,
  • E. M. Meulenbroek,
  • I. Baas,
  • S. R. Janssen,
  • E. E. Dijkman,
  • K. A. Gelderman,
  • D. Wouters,
  • M. D. Engel,
  • M. de Haas,
  • M.-J. Kersten,
  • I. Jongerius,
  • S. Zeerleder,
  • J. M. Vos

DOI
https://doi.org/10.1097/01.HS9.0000848976.85981.b3
Journal volume & issue
Vol. 6
pp. 1411 – 1412

Abstract

Read online

No abstracts available.